Crinetics Pharmaceuticals(CRNX) - 2024 Q1 - Quarterly Report
Crinetics Pharmaceuticals(CRNX)2024-05-09 20:38UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 CRINETICS PHARMACEUTICALS, INC. QUARTERLY REPORT ON FORM 10-Q For the Quarter Ended March 31, 2024 | --- | --- | |----------|-------| | | | | | | | | | | Item 1. | | | Item 1A. | | | Item 2. | | | | | | Item 3. | | | Item 4. | | | Item 5. | | | Item 6. | | Item 1. Condensed Financial Statemen ...